Economy of Germany

Global Pharmaceutical Glass Tubing Market Report 2021-2026: Growth, Trends, COVID-19 Impact, and Forecasts Featuring Schott, Nipro Pharma, Corning, and Nippon Electric Glass - ResearchAndMarkets.com

Retrieved on: 
Mercredi, août 4, 2021

The "Global Pharmaceutical Glass Tubing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pharmaceutical Glass Tubing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • However, the pharmaceutical glass tubing market's outlook remains positive due to the growth in vaccines and drugs by the pharmaceutical industry.
  • The Global Pharmaceutical Glass Tubing market is moderately consolidated, owing to the presence of many regional and global players.
  • Some of the players in the market are Schott AG, Nipro Pharma Corporation, Corning Incorporated, and Nippon Electric Glass Co. Ltd

DGAP-News: Daimler International Finance B.V.: The Interim Report 2021 as of 30 June 2021 of Daimler International Finance B.V. is now available online

Retrieved on: 
Mardi, août 3, 2021

Daimler International Finance B.V.: The Interim Report 2021 as of 30 June 2021 of Daimler International Finance B.V. is now available online

Key Points: 
  • Daimler International Finance B.V.: The Interim Report 2021 as of 30 June 2021 of Daimler International Finance B.V. is now available online
    The issuer is solely responsible for the content of this announcement.
  • The Interim Report 2021 as of 30 June 2021 of Daimler International Finance B.V. is available on
    and related regulations of Luxembourg.
  • This information has been issued by Daimler International Finance B.V. and Daimler AG.
  • Daimler
    International Finance B.V. finances parts of the activities of the Daimler Group.

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

Retrieved on: 
Mardi, août 3, 2021

In July, Boehringer Ingelheim reported a breakthrough in the treatment of heart failure with empagliflozin (marketed as JARDIANCE).

Key Points: 
  • In July, Boehringer Ingelheim reported a breakthrough in the treatment of heart failure with empagliflozin (marketed as JARDIANCE).
  • Boehringer Ingelheim also made progress in the area of neuropsychiatric disorders, including two ongoing phase II trials.
  • Quantum computing holds enormous potential for pharmaceutical research and development, particularly for early research processes in which Boehringer Ingelheim has a high level of expertise.
  • Following a successful financial year 2020, Boehringer Ingelheim continued its positive trend in the first half of 2021.

DGAP-News: Vonovia SE: Vonovia intends to submit new takeover offer to Deutsche Wohnen shareholders in the near future

Retrieved on: 
Mardi, août 3, 2021

On this basis, Vonovia intends to submit a new voluntary takeover offer to the shareholders of Deutsche Wohnen in the near future, maintaining the key parameters of the offer made on 23 June 2021.

Key Points: 
  • On this basis, Vonovia intends to submit a new voluntary takeover offer to the shareholders of Deutsche Wohnen in the near future, maintaining the key parameters of the offer made on 23 June 2021.
  • Subject to their review of the new offer document, the boards of Deutsche Wohnen intend to recommend such an offer to their shareholders.
  • Our plans also have the backing of key shareholders of Vonovia and Deutsche Wohnen.
  • The public takeover offer to the shareholders of Deutsche Wohnen on 23 June, with an acceptance level of 47.62%, failed to reach the minimum acceptance threshold.

DGAP-News: Deutsche Wohnen SE: Deutsche Wohnen supports improved offer by Vonovia to combine both companies

Retrieved on: 
Mardi, août 3, 2021

Deutsche Wohnen SE ("Deutsche Wohnen") and Vonovia SE ("Vonovia") continue to pursue a business combination of both companies in partnership.

Key Points: 
  • Deutsche Wohnen SE ("Deutsche Wohnen") and Vonovia SE ("Vonovia") continue to pursue a business combination of both companies in partnership.
  • In this context, Vonovia plans to launch a renewed improved voluntary public takeover offer for all outstanding shares of Deutsche Wohnen in the near future.
  • Michael Zahn, CEO of Deutsche Wohnen: "A combination with Vonovia in partnership still makes strategic sense and offers significant benefits.
  • The existing business combination agreement of Deutsche Wohnen and Vonovia was adjust-ed in view of the parameters of the improved offer.

Bayer Fund Teams with Farmers to Direct Funds to Local Nonprofits, Schools and Ag Programs

Retrieved on: 
Lundi, août 2, 2021

For 2022, Bayer Fund will double the individual donations to $5,000, up from $2,500 in previous years.

Key Points: 
  • For 2022, Bayer Fund will double the individual donations to $5,000, up from $2,500 in previous years.
  • America's Farmers initiatives have awarded more than $60 million to thousands of schools and nonprofit organizations.
  • "We can't thank our local farmers and the Grow Communities program enough for their donation and continued support," said Beth Burrow, Greenfield High School's ag instructor.
  • America's Farmers, sponsored by Bayer Fund, is focused on strengthening rural America through community outreach programs that partner with farmers to make an impact in communities where farmers live and work.

DGAP-News: Schaeffler AG: CFO Dr. Klaus Patzak is leaving Schaeffler AG

Retrieved on: 
Vendredi, juillet 30, 2021

Herzogenaurach | July 30, 2021 | Dr. Klaus Patzak (56), Chief Financial Officer (CFO) of Schaeffler AG, has informed the Supervisory Board of Schaeffler AG of his wish to leave the company effective July 31, 2021.

Key Points: 
  • Herzogenaurach | July 30, 2021 | Dr. Klaus Patzak (56), Chief Financial Officer (CFO) of Schaeffler AG, has informed the Supervisory Board of Schaeffler AG of his wish to leave the company effective July 31, 2021.
  • Dr. Patzak was appointed CFO, which includes responsibility for Finance & IT, as a member of the Board of Managing Directors of Schaeffler AG on August 1, 2020.
  • On behalf of the Supervisory Board, I would like to thank him for his contribution to Schaeffler AG during the twelve months he headed Finance & IT.
  • We wish Dr. Patzak all the best for his personal and professional future," said Georg F. W. Schaeffler, family shareholder and Chairman of the Supervisory Board of Schaeffler AG.

TUI Group: Sale of stake in real-estate portfolio to Riu family completed

Retrieved on: 
Vendredi, juillet 30, 2021

The TUI Group has successfully completed the sale of its minority stake in a property portfolio to the Riu family.

Key Points: 
  • The TUI Group has successfully completed the sale of its minority stake in a property portfolio to the Riu family.
  • The portfolio, which was previously held jointly between TUI and RIU, consists of 21 properties, comprising 19 existing buildings and two in development.
  • Fritz Joussen, CEO of TUI Group: "With the sale of properties TUI sharpens its long-standing successful partnership with RIU and the Riu family and creates the basis for profitability and new growth after the pandemic.
  • TUI continues to strengthen its core business with holiday experiences and intends to grow its international hotel brands TUI Blue, RIU, Robinson, TUI Magic Life.

DGAP-News: GRENKE AG raises profit forecast for 2021

Retrieved on: 
Mercredi, juillet 28, 2021

Consolidated Group net profit of EUR 60-80 million expected (previous forecast: EUR 50-70 million)

Key Points: 
  • Consolidated Group net profit of EUR 60-80 million expected (previous forecast: EUR 50-70 million)
    Baden-Baden, July 28, 2021: GRENKE AG, a global financing partner for small and medium-sized enterprises, is raising its profit forecast for 2021.
  • According to preliminary figures, Consolidated Group net profit reached EUR 32 million in the first six months(1H 2020: EUR 33.2 million).
  • Based on the preliminary half-year figures for 2021, the need for risk provisioning ended up decreasing.
  • The Board of Directors of GRENKE AG expects this to continue in the second half of 2021.

DGAP-News: HELLA GmbH & Co. KGaA: HELLA continues to grow more rapidly than the automotive market even in a challenging market environment

Retrieved on: 
Mercredi, juillet 28, 2021

Currency and portfolio-adjusted consolidated sales increased by 13.3 percent to 6.5 billion (prior year: 5.7 billion).

Key Points: 
  • Currency and portfolio-adjusted consolidated sales increased by 13.3 percent to 6.5 billion (prior year: 5.7 billion).
  • With these preliminary financial results, HELLA is in the upper reaches of the forecast ranges raised in December 2020.
  • Accordingly, the company has continued to grow more rapidly than the global automotive market.
  • Furthermore, in its Special Applications segment, HELLA develops, manufactures and sells lighting and electronic products for specialist vehicles.